PXMD - PaxMedica, Inc. Stock Price, Fair Value and News

$0.070.00 (0.00%)

Delayed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

PXMD Price Action

Last 30 days

-30%

Last 90 days

-30%

Trailing 12 Months

-91.4%

PXMD RSI Chart

PXMD Valuation

Market Cap

761.5K

Price/Earnings (Trailing)

-0.04

Price/Free Cashflow

-0.08

PXMD Price/Earnings (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

PXMD Fundamentals

PXMD Earnings

Earnings (TTM)

-17.7M

Earnings Growth (Yr)

14.01%

Earnings Growth (Qtr)

18.83%

PXMD Profitability

Return on Equity

977.01%

Return on Assets

-2.2K%

Free Cashflow Yield

-1.2K%

PXMD Investor Care

Shares Dilution (1Y)

913.13%

Diluted EPS (TTM)

-2.69

Revenue & Growth

About PaxMedica, Inc.

PaxMedica, Inc., a clinical stage biopharmaceutical company, focuses on the development of anti-purinergic drug therapies (APT) for the treatment of disorders with intractable neurologic symptoms. The company's lead product candidate is PAX-101, an intravenous formulation of suramin for various indications, including autism spectrum disorder, myalgic encephalomyelitis/chronic fatigue syndrome, long COVID-19 syndrome, and human African trypanosomiasis (HAT). It also develops PAX-102, an intranasal formulation of suramin for neurologic indications; and HAT-301 for the treatment of stage 1 East African HAT. The company has a research collaboration with PoloMar Health to investigate the use of emodin in a clinical program as a potential treatment for patients with autism spectrum disorder The company was formerly known as Purinix Pharmaceuticals LLC and changed its name to PaxMedica, Inc. in April 2020. PaxMedica, Inc. was incorporated in 2018 and is based in Tarrytown, New York.

CEO	Mr. Howard J. Weisman
WEBSITE	paxmedica.com
SECTOR	Healthcare
INDUSTRY	Biotechnology
EMPLOYEES	3

PaxMedica, Inc. Frequently Asked Questions

What is the ticker symbol for PaxMedica, Inc.? What does PXMD stand for in stocks?

PXMD is the stock ticker symbol of PaxMedica, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of PaxMedica, Inc. (PXMD)?

As of Fri Dec 20 2024, market cap of PaxMedica, Inc. is 761.54 Thousand. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of PXMD stock?

You can check PXMD's fair value in chart for subscribers.

Is PaxMedica, Inc. a good stock to buy?

The fair value guage provides a quick view whether PXMD is over valued or under valued. Whether PaxMedica, Inc. is cheap or expensive depends on the assumptions which impact PaxMedica, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for PXMD.